HCW Biologics Inc

NASDAQ HCWB

Data sourced from iex and EODHD
Download Data

HCW Biologics Inc Income Statement 2020 - 2024

This table shows the Income Statement for HCW Biologics Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue
M 1 1 1 1 0 1 2 0 3 0 0 0 0 4 0 0 -
Cost of Revenue
M 1 1 1 1 0 1 1 0 1 - - - - - - - -
Gross Profit
M 0 0 0 0 0 0 0 0 2 - - - - 4 - - -
Operating Expenses
M 11 11 5 5 5 6 4 4 4 - - - - 2 - - -
Selling, General, and Administrative Expenses (SG&A)
M 4 4 4 3 3 3 2 2 2 2 1 1 1 1 1 1 1
Research and Development (R&D) Expenses
M 2 2 2 2 2 3 3 2 2 1 3 2 2 1 2 2 2
Other Operating Expenses
M 5 5 0 0 0 0 0 0 0 - - - - 0 - - -
Costs and Expenses
M 9 11 5 4 5 5 3 3 2 - - - - - - - -
Operating Income
M -11 -11 -5 -5 -5 -6 -4 -4 -2 -3 -4 -3 -3 2 -3 -3 -2
Interest Expense
M 0 0 0 0 0 0 0 0 0 1 0 - 1 0 0 - 0
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
EBT
M -11 -11 -5 -4 -5 -5 -4 -4 -2 -3 -4 -3 -3 2 -3 -3 -2
Income Tax Provision
M -1 - 0 0 0 0 0 0 0 0 - - - - - - -
Income after Tax
M -10 - -5 -5 -5 -5 -4 -4 -2 -3 - - - - - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 -
Net Income
M - - - -4 -5 -5 -4 -4 -2 -3 -4 -3 -3 - -3 -3 -3
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 35,996,415.00 36,025,104.00 35,926,921.00 35,910,669.00 35,883,779.00 35,861,348.00 35,835,135.00 35,814,482.00 35,778,032.00 29,572,267.00 29,572,267.00 34,250,520.00 34,250,520.00 28,608,291.00 28,608,291.00 28,608,291.00 28,608,291.00
EBITDA
M -10 - -5 -4 -5 -6 -4 -3 -2 -3 -4 -3 -3 2 -3 -3 -2
Depreciation and Amortization
M 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -11 - -5 -4 -5 -6 -4 -4 -2 -3 -4 -3 -3 2 -3 -3 -2
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 4.97 - -6.69 -9.23 3.87 1.34 2.69 0.01 -8.57 0.00 - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% -1.65 19.08 20.49 19.33 29.92 20.00 20.00 36.74 57.40 - - - - 100.00 - - -
Operating Income Margin
% -813.31 -813.31 -595.23 -724.22 -12,798.92 -422.45 -222.20 -773.36 -60.33 - - - - 50.27 - - -
Net Income Margin
% - - - -691.13 -12,106.79 -403.93 -216.37 -773.25 -65.99 - - - - - - - -
EBITDA Ratio
% -792.57 - -535.18 -630.14 -11,883.70 -422.45 -213.12 -740.42 -55.75 - - - - 54.27 - - -
EBIT Ratio
% -813.31 - -567.71 -675.80 -12,798.92 -441.92 -222.20 -773.36 -60.33 - - - - 50.27 - - -
EBT Ratio
% -806.69 -806.69 -578.90 -691.13 -12,106.79 -403.93 -216.37 -773.25 -65.99 - - - - 50.27 - - -

StockViz Staff

September 19, 2024

Any question? Send us an email